HIDA Scan Market Analysis

HIDA Scan Market Overview

HIDA Scan Market Size was valued at USD 0.2 Billion in 2023. The Global HIDA Scan industry is projected to grow from USD 0.3 Billion in 2024 to USD 0.8 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.43% during the forecast period (2024 - 2032). Also known as cholescintigraphy and hepatobiliary scintigraphy, HIDA scan is an imaging test used for the diagnosis of a number of problems such as liver, gallbladder, and bile duct.

In October 2023, South African healthcare providers joined hands with GE Healthcare to unveil the CardioCare™ V100 Ventilator. The primary goal of this pact is to provide portable and affordable critical care solutions within the region.

To lessen the scarcity of advanced diagnostic services, Siemens Healthineers increased its service network in Saudi Arabia in November 2023, which would ensure better technical support and maintenance for critical care equipment.

Mindray Medical International launched a new manufacturing facility in Kenya in January 2024. The main objective of this facility is to facilitate the manufacture and affordability of life support machines in order to meet the growing demand in Africa.

Draegwerwerk AG & Co. KGaA has teamed up with one of UAE’s top healthcare providers to introduce a cloud-based patient monitoring system that gives us real time information on patients in critical care environment.

Cholecystitis, bile duct obstruction, biliary atresia, postoperative complications, and assessment of liver transplant are the major indications that can be diagnosed using HIDA scan, which is a better alternative to CT, MRI, and X-ray examination. During HIDA scan, a radioactive tracer, injected in the vein, travels through the bloodstream to the liver, and the bladder and screen the same for any abnormality.

Gall bladder diseases affect a large number of people in the world. Approximately, 10–15% of adults in the developed countries are suffering from gallstones. Gallbladder and biliary related diseases occurred in about 104 million people (1.6%) in 2013.

The HIDA scan market is driven majorly by increasing number of people suffering from gall bladder diseases, development of technologically advanced devices, increasing awareness among people about diagnosis of gall bladder, and liver disease. Additionally, increasing healthcare expenditure by developed economies such as the U.S is another important factor for fuelling the growth of the market. Moreover, increasing geriatric population, and introduction of new & advanced diagnostic options to cure gallbladder problems have fuelled the market growth

Key Players in the HIDA Scan Market

Some of the key players in  HIDA scan market are: 

• Houston Medical Imaging (U.S.)


• Bracco Diagnostic Inc. (U.S.)


• Buffalo MRI (U.S.)


• Siemens (U.S.)


• DDD- Diagnostics A/S (Germany)


• Digirad Corporation (U.S.)


• General Electric Company (U.S.)


• Koninklijke Philips N.V. (Japan)


• Toshiba Medical Systems Corporation (Japan)

HIDA Scan Market Segmentation

The HIDA scan market is segmented on the basis of product, indication, and end user.

On the basis of product, the HIDA scan market is segmented into radiopharmaceuticals, HIDA Scan, and others.

On the basis of indication, the HIDA scan market is segmented into cholecystitis, bile duct obstruction, biliary atresia, postoperative complications, assessment of liver transplant, and others. Postoperative complications is sub-segmented into bile leaks, and fistulas.

On the basis of end user, the HIDA scan market is segmented into orthopedic hospitals & clinics, diagnostic centers, and others.

Regional Analysis of the Global HIDA Scan Market

Considering the global scenario of the gall bladder treatment market, there are four main regions: America, Europe, Asia Pacific, and the Middle East & Africa.

America accounts for the largest market share owing to the presence of huge patient population suffering from gall bladder diseases. A well-developed healthcare sector and high healthcare spending has also accelerated the growth of the market. America consists of two regions namely, North America and South America. North America is the major market share holder owing to the presence of key players in the market offering radioactive imaging technology devices. Additionally, the key players in the market are focusing on strategies such as acquisition, partnerships, product development, and others.

Europe holds the second largest market share in HIDA scan market. Some major factors that attribute the growth of Europe gall bladder treatment market is, increasing government support for researched development in diagnosis of chronic diseases. Germany, France and U.K are the major contributors to the Europe gall bladder treatment market owing to increasing demand for the technological advanced devices, and overall growth of healthcare sector.

Asia Pacific is the fastest growing market. Improving healthcare infrastructure, presence of huge patient population, rising awareness about gall bladder treatment has driven the growth for this market in Asia Pacific. India is expected to be the fastest growing market owing to increasing government support for healthcare industry, and increasing demand for new imaging devices in the market.

The Middle East & Africa account for the lowest share in the global HIDA scan owing to positive growth of healthcare sector form last few years. This limited growth is mainly due to lack of awareness of the disease, and limited access to the healthcare facilities. While due to developed healthcare infrastructure, government support and increasing healthcare expenditure, the Middle Eastern countries like United Arab Emirates (UAE), and Saudi Arabia are dominating this market.

Intended Audience

• Arthritis Drug Manufacturers


• Arthritis Drug Suppliers


• Medical Research Laboratories


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors